We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Latest Drug Safety List Includes Abilify, Plan B
FDA’s Latest Drug Safety List Includes Abilify, Plan B
February 6, 2009
Postmarketing surveillance by the FDA revealed potential risks of heart and blood disorders associated with Bristol-Myers Squibb and Otsuka’s schizophrenia drug Abilify.